Sanofi Genzyme to lay off 130 employees at Boston plant

Sanofi Genzyme will lay off 130 workers this week at its manufacturing plant in Boston in an effort to reduce costs and simplify operations, according to the Boston Globe.

Advertisement

The layoffs will only affect employees at the Allston Landing plant, which is a biomanufacturing site.

“We must be flexible in our operations to remain competitive in a dynamic and challenging healthcare environment,” said Ashleigh Koss, spokeswoman for Sanofi SA, the French parent company, according to the Boston Globe.

Sanofi Genzyme is a rare disease division of Sanofi SA. It employs about 5,000 employees in Massachusetts.

More articles on supply chain:
Celgene Executive Chairman Bob Hugin abruptly steps down: 5 things to know
As flu rages throughout Florida, Tamiflu supplies run low
Pfizer’s opioid-filled syringes hit another manufacturing snag: 6 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.